איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - Öll önnur lækningavörur - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

genzyme europe bv - sevelamer hýdróklóríð - hyperphosphatemia; renal dialysis - Öll önnur lækningavörur - tasermity er ætlað til að stjórna blóðfosfathækkun hjá fullorðnum sjúklingum sem fá blóðskilun eða kviðskilun. sevelamer stutt og long-term ætti að vera notuð í samhengi margar læknlngar, sem gæti verið kalk, 1,25 dihydroxy d3 vítamín eða einn af hliðstæðum til að stjórna þróun skert beinum.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Ónæmisbælandi lyf - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - sevelamerum karbónat - filmuhúðuð tafla - 800 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

laboratorios normon, s.a. - metronidazolum inn - innrennslislyf, lausn - 5 mg/ml